215 related articles for article (PubMed ID: 21481559)
1. Simultaneous determination of a p38 MAP kinase inhibitor and its amide hydrolyzed metabolite in Cynomolgus monkey plasma by LC-MS/MS, and its application to a toxicokinetic study.
Akrami A; Hsieh F; Almon V; Bruenner BA; James C; Wong P
J Pharm Biomed Anal; 2011 Jul; 55(5):1104-10. PubMed ID: 21481559
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of pasireotide (SOM230), a cyclic peptide, in monkey plasma using liquid chromatography in combination with tandem mass spectrometry.
Fu Y; Li W; Flarakos J; Tse FLS
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():242-249. PubMed ID: 26680325
[TBL] [Abstract][Full Text] [Related]
4. Determination of dihydromyricetin in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.
Tong Q; Hou X; Fang J; Wang W; Xiong W; Liu X; Xie X; Shi C
J Pharm Biomed Anal; 2015 Oct; 114():455-61. PubMed ID: 26133104
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
[TBL] [Abstract][Full Text] [Related]
6. Determination of oxaceprol in rat plasma by LC-MS/MS and its application in a pharmacokinetic study.
Gu J; Chen N; Ding G; Zhang Z
J Pharm Biomed Anal; 2011 Jan; 54(1):173-8. PubMed ID: 20832228
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of an LC-MS/MS method for quantitative determination of GS87, a novel antineoplastic agent, in mouse plasma.
Kunati SR; Yang S; Wald D; Xu Y
J Pharm Biomed Anal; 2018 May; 153():145-151. PubMed ID: 29482106
[TBL] [Abstract][Full Text] [Related]
8. Determination of chamaechromone in rat plasma by liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study.
Lou Y; Hu H; Liu Y; Yu Q; Li L; Ping L; Yu L; Jiang H; Zeng S
J Pharm Biomed Anal; 2011 Jul; 55(5):1163-9. PubMed ID: 21549539
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of sensitive and selective LC-MS/MS methods for the determination of BMS-708163, a gamma-secretase inhibitor, in plasma and cerebrospinal fluid using deprotonated or formate adduct ions as precursor ions.
Gu H; Deng Y; Wang J; Aubry AF; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2319-26. PubMed ID: 20674522
[TBL] [Abstract][Full Text] [Related]
10. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
Li W; Lin H; Fu Y; Flarakos J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
[TBL] [Abstract][Full Text] [Related]
11. Determination of ticagrelor and two metabolites in plasma samples by liquid chromatography and mass spectrometry.
Sillén H; Cook M; Davis P
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2299-306. PubMed ID: 20688583
[TBL] [Abstract][Full Text] [Related]
12. Quantitative determination of Lx2-32c, a novel taxane derivative, in rat plasma by liquid chromatography-tandem mass spectrometry.
Hu J; You F; Yang S; Li Y
J Pharm Biomed Anal; 2014 Jan; 88():483-8. PubMed ID: 24176754
[TBL] [Abstract][Full Text] [Related]
13. A validated LC-MS/MS assay for the simultaneous determination of periplocin and its two metabolites, periplocymarin and periplogenin in rat plasma: Application to a pharmacokinetic study.
He J; Bo F; Tu Y; Azietaku JT; Dou T; Ouyang H; Chang Y; Liu H; Gao X
J Pharm Biomed Anal; 2015 Oct; 114():292-5. PubMed ID: 26093244
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a sensitive LC-MS/MS assay for simultaneous quantitation of ranolazine and its three metabolites in human plasma.
Wang Y; Chen X; Sun Z; Yang Y; Zhang Y; Liu W; Zhong D
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 889-890():10-6. PubMed ID: 22377406
[TBL] [Abstract][Full Text] [Related]
15. Determination of a peroxisome proliferator-activated receptor γ agonist, 1-(trans-methylimino-N-oxy)-6-(2-morpholinoethoxy-3-phenyl-1H-indene-2-carboxylic acid ethyl ester (KR-62980) in rat plasma by liquid chromatography-tandem mass spectrometry.
Kim MS; Song JS; Roh H; Park JS; Ahn JH; Ahn SH; Bae MA
J Pharm Biomed Anal; 2011 Jan; 54(1):121-6. PubMed ID: 20729023
[TBL] [Abstract][Full Text] [Related]
16. A validated enantioselective LC-MS/MS assay for quantification of a major chiral metabolite of an achiral 11-β-hydroxysteroid-dehydrogenase 1 inhibitor in human plasma: Application to a clinical pharmacokinetic study.
Furlong MT; Ji QC; Iacono L; Dang O; Noren M; Bruce J; Aubry AF; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():167-172. PubMed ID: 27100678
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a LC-MS/MS method for the quantitation of lumefantrine in mouse whole blood and plasma.
Govender K; Gibhard L; Du Plessis L; Wiesner L
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():6-13. PubMed ID: 25647340
[TBL] [Abstract][Full Text] [Related]
18. LC-MS/MS method for the determination of several drugs used in combined cardiovascular therapy in human plasma.
Gonzalez O; Iriarte G; Rico E; Ferreirós N; Maguregui MI; Alonso RM; Jiménez RM
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2685-92. PubMed ID: 20846917
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
[TBL] [Abstract][Full Text] [Related]
20. Determination of YZG-331 in mouse plasma using liquid chromatography-tandem mass spectrometry.
Liu Z; Sheng L; Li Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():6-10. PubMed ID: 24291606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
